Evidence supporting the beneficial impact of physiological hypeprolactinemia (in pregnancy and after breastfeeding) on RA is reinforced by experimental studies showing that sustained PRL administration or genetic deletion of the PRL receptor ameliorates or worsens the severity of inflammatory arthritis, respectively. Here, PRL is linked to rheumatoid arthritis.